Gefitinib in treatment of advanced non-small-cell lung cancer as a last treatment option on an Expanded Access Program

被引：0
|
作者：
Zemanova, M [1 ]
Petruzelka, L [1 ]
Honova, H [1 ]
Dvorak, J [1 ]
Safanda, M [1 ]
Mares, P [1 ]
Tomancova, V [1 ]
机构：
[1] Med Univ Gdansk, Dept Radiotherapy & Oncol, Gdansk, Poland
来源：
LUNG CANCER | 2004年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S82 / S83
页数：2
相关论文
共 50 条
  • [41] Surrogate end points for survival in the target treatment of advanced non-small-cell lung cancer with gefitinib or erlotinib
    Xiaoqin Li
    Shan Liu
    Hangang Gu
    Deqiang Wang
    Journal of Cancer Research and Clinical Oncology, 2012, 138 : 1963 - 1969
  • [42] Surrogate end points for survival in the target treatment of advanced non-small-cell lung cancer with gefitinib or erlotinib
    Li, Xiaoqin
    Liu, Shan
    Gu, Hangang
    Wang, Deqiang
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (11) : 1963 - 1969
  • [43] First-Line Single Agent Treatment With Gefitinib in Advanced Non-Small-Cell Lung Cancer Patients
    Yin, Yong-mei
    BIOMEDICINE & PHARMACOTHERAPY, 2009, 63 (05) : 325 - 325
  • [44] Treatment of non-small-cell lung cancer: a perspective on the recent advances and the experience with gefitinib
    A Onn
    M Tsuboi
    N Thatcher
    British Journal of Cancer, 2004, 91 : S11 - S17
  • [45] Gefitinib ('Iressa', ZD1839) as treatment for non-small-cell lung cancer
    Razis, E
    Papadopoulos, S
    Skarlos, D
    Exarchakos, M
    Christodoulou, C
    Karina, M
    Xylouri, M
    Labropoulos, S
    BRITISH JOURNAL OF CANCER, 2003, 89 : S32 - S32
  • [46] Gefitinib treatment affects androgen levels in non-small-cell lung cancer patients
    Nishio, M
    Ohyanagi, F
    Horiike, A
    Ishikawa, Y
    Satoh, Y
    Okumura, S
    Nakagawa, K
    Nishio, K
    Horai, T
    BRITISH JOURNAL OF CANCER, 2005, 92 (10) : 1877 - 1880
  • [47] Gefitinib treatment affects androgen levels in non-small-cell lung cancer patients
    M Nishio
    F Ohyanagi
    A Horiike
    Y Ishikawa
    Y Satoh
    S Okumura
    K Nakagawa
    K Nishio
    T Horai
    British Journal of Cancer, 2005, 92 : 1877 - 1880
  • [48] Treatment of non-small-cell lung cancer: a perspective on the recent advances and the experience with gefitinib
    Onn, A
    Tsuboi, M
    Thatcher, N
    BRITISH JOURNAL OF CANCER, 2004, 91 (Suppl 2) : S11 - S17
  • [49] Standing the test of time in Europe? Gefitinib in the treatment of non-small-cell lung cancer
    Wilson, Caroline
    Danson, Sarah J.
    LUNG CANCER-TARGETS AND THERAPY, 2010, 1 : 37 - 51
  • [50] Role of gefitinib in the targeted treatment of non-small-cell lung cancer in Chinese patients
    Li, Meng-Jiao
    He, Qing
    Li, Mei
    Luo, Feng
    Guan, Yong-Song
    ONCOTARGETS AND THERAPY, 2016, 9 : 1291 - 1302
12345